AAOS Announces 2021 MORE Award Recipients

The American Academy of Orthopaedic Surgeons (AAOS) is pleased to announce the recipients of the 2021 Media Orthopaedic Reporting Excellence (MORE) Awards. Presented annually to U.S.-based journalists, the MORE Awards acknowledge accurate reporting of musculoskeletal health news topics and celebrate the role media play in accurately educating and informing patients about musculoskeletal health issues, innovative bone and joint treatments, preventative care and patient recovery.

Entries were judged by a panel of orthopaedic surgeons and evaluated for overall quality and medical accuracy. The winners of the 2021 awards include health and medical writers, photographers and freelance reporters from print, broadcast and online media outlets. From heart-warming patient stories to perspectives on orthopaedic innovations and treatment options, the award recipients covered an array of bone and joint-health topics.

“Having trusted sources of information that increase the public’s knowledge of bone and joint conditions and issues that impact patient care is important,” said Daniel K. Guy, MD, FAAOS, AAOS President. “We gratefully acknowledge the media’s commitment to delivering compelling and accurate reporting. The AAOS is honored to sponsor the MORE Awards, a long-standing program that recognizes the positive impact that journalism plays in sharing stories of patients’ perseverance and their successes.”

The 2021 MORE Award winners by category are:

Newspaper/Magazine Feature

Broadcast Feature

Online Journalism

The AAOS has bestowed more than 300 MORE Awards since the program’s inception in 2006.

Hot this week

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Haemonetics notes the VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.